A. Ashek

发表

Heterogeneity in Lung 18FDG Uptake in Pulmonary Arterial Hypertension: Potential of Dynamic 18FDG Positron Emission Tomography With Kinetic Analysis as a Bridging Biomarker for Pulmonary Vascular Remodeling Targeted Treatments

S. Pullamsetti, S. Dabral, W. Fang, 2013, Circulation.

Activation of Thiazide-Sensitive Co-Transport by Angiotensin II in the cyp1a1-Ren2 Hypertensive Rat

A. Harmar, J. Mullins, M. Bailey, 2012, PloS one.

A combined approach of docking and 3D QSAR study of beta-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.

S. Cho, A. Ashek, 2006, Bioorganic & medicinal chemistry.

Angiotensin-converting Enzyme Is a Modifier of Hypertensive End Organ Damage

J. Mullins, M. Bailey, L. Mullins, 2009, The Journal of Biological Chemistry.

Iron homeostasis and pulmonary hypertension: iron deficiency leads to pulmonary vascular remodeling in the rat.

Lan Zhao, E. Cotroneo, J. Wharton, 2015, Circulation research.

Rational : Iron deficiency without anaemia is prevalent in patients with idiopathic pulmonary arterial hypertension and associated with reduced exercise capacity and survival

Lan Zhao, E. Cotroneo, J. Wharton, 2015 .

Integrative Physiology Methods and Results: Rats Were Fed an Iron-deficient Diet (idd, 7 Mg/kg) and Investigated for 4 Weeks. Iron Deficiency Was Evident from Depleted Iron Stores (decreased Liver, Serum Iron, and Ferritin), Reduced Erythropoiesis, and Significantly Decreased Transferrin Saturation

Lan Zhao, E. Cotroneo, J. Wharton, 2022 .

3D QSAR studies of dioxins and dioxin-like compounds using CoMFA and CoMSIA.

S. Cho, Cheolju Lee, Hyunsung Park, 2006, Chemosphere.

Correction of a chronic pulmonary disease through lentiviral vector-mediated protein expression

S. Hyde, D. Gill, E. Alton, 2022, Molecular therapy. Methods & clinical development.

Effective Detection and Monitoring of Glioma Using [18F]FPIA PET Imaging

E. Aboagye, A. Hajitou, A. Carcaboso, 2021, Biomedicines.

Application of [18F]FLT-PET in pulmonary arterial hypertension: a clinical study in pulmonary arterial hypertension patients and unaffected bone morphogenetic protein receptor type 2 mutation carriers

Lan Zhao, A. Noordegraaf, H. Bogaard, 2021, Pulmonary circulation.

3′-Deoxy-3′-[18F]Fluorothymidine Positron Emission Tomography Depicts Heterogeneous Proliferation Pathology in Idiopathic Pulmonary Arterial Hypertension Patient Lung: A Potential Biomarker for Pulmonary Arterial Hypertension

R. Boellaard, A. Lammertsma, S. Pullamsetti, 2018, Circulation. Cardiovascular imaging.

FLT PET depicts heterogeneous proliferation pathology in IPAH patient lung: a potential biomarker for PAH

R. Boellaard, A. Lammertsma, S. Dabral, 2018 .

Heterogeneity in Lung 18 FDG Uptake in PAH: Potential of Dynamic 18 FDG-PET with Kinetic Analysis as a Bridging Biomarker for Pulmonary Remodeling Targeted Treatments

S. Pullamsetti, S. Dabral, M. El-Bahrawy, 2013 .

Iron Homeostasis and Pulmonary Hypertension Iron Deficiency Leads to Pulmonary Vascular Remodeling in the Rat

Lan Zhao, E. Cotroneo, J. Wharton, 2015 .

SOX17 enhancer variants disrupt transcription factor binding and enhancer inactivity drives pulmonary hypertension

N. Morrell, O. Liang, Lan Zhao, 2023, Circulation.

Evaluation of [18F]AlF-EMP-105 for Molecular Imaging of C-Met

E. Aboagye, J. H. Teh, Ning Wang, 2023, Pharmaceutics.

HQSAR study of β-ketoacyl‐acyl carrier protein synthase III (FabH) inhibitors

S. Cho, Ali Ashek, Amor A. San Juan, 2007 .